# The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-anti-her3-antibody-patritumab-abrogates-cetuximab-resistance-mediated-by/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hisato Kawakami,Isamu Okamoto,Kimio Yonesaka,Kunio Okamoto,Kiyoko Shibata,Yume Shinkai,Haruka Sakamoto,Michiko Kitano,Takao Tamura,Kazuto Nishio,Kazuhiko Nakagawa |
| Citations | 80 |
| DOI | 10.18632/oncotarget.2663 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://www.oncotarget.com/article/2663/pdf/ |
| OpenAlex ID | https://openalex.org/W1544959878 |
| PMID | 25474137 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Kunio Okamoto](https://scholariq.org/researchers/kunio-okamoto/)

## Paper journal

- [Oncotarget](https://scholariq.org/journals/oncotarget/)

## Paper primary topic

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

## Paper topics

- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Glycosylation and Glycoproteins Research](https://scholariq.org/topics/glycosylation-and-glycoproteins-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.